Control Bionics (ASX: CBL) registers NeuroStrip with US FDA as commercial execution becomes the next test
Read More Auto and Transport Industry News easyJet rejects £4.74bn Castlelake proposal as EZJ board defends standalone value easyJet has rejected Castlelake’s third takeover proposal at 625 pence a share, arguing that the £4.74 billion approach undervalues its fleet renewal, holidays business and long-term earnings potential. byVenkateshJune 22, 2026